State coverage
Medicaid, for obesity: Covers with conditions. The conditions and the appeal deadline are in the summary below.
North Carolina is the state that makes any tally of who covers what look unreliable, because within one quarter it was in both columns. On September 5, 2025 the state published a bulletin ending coverage of GLP-1s for obesity, and it said why in plain terms: the money had run out. On December 19 it published another one putting the coverage back, effective a week earlier, and reverting to the criteria that had been in force before.
So a page that counted states in November got North Carolina wrong by December, and a page that counted in January got it right for the wrong reason. Both bulletins are dated, both are still up, and both say they apply to NC Medicaid Direct and NC Medicaid Managed Care. If you need the citable document — the thing a reporter has to produce on deadline — it is those two bulletins side by side.
What you actually have to clear is the part that survived all of it. The criteria set a body mass index floor, ask your prescriber to record your baseline weight measured within the past 45 days, require that you are on and staying on structured nutrition and physical activity, and then test you at renewal: adults have to have lost 5% of their pretreatment weight and kept it off. Wegovy is the preferred product, so Zepbound or Saxenda means showing first that Wegovy did not work for you or that you cannot take it.
One honesty note about our sourcing. The criteria document we could open carries a DRAFT watermark on every page and a submission footer, and the URL the state's own bulletin gives for the current criteria returned a 404 on August 31, 2026 while the newer route sits behind a login. We checked the draft against the live prior authorization form on the state's claims portal, which asks the same questions in the same order, and we are telling you the document's status rather than presenting it as final.
North Carolina ended this coverage first. Its September 2025 bulletin says: "Given shortfalls in state funding, effective Oct. 1, 2025, NC Medicaid coverage for GLP-1s for the treatment of obesity, which is an optional benefit for Medicaid programs, will be discontinued." It also says what stayed — coverage continued for diabetes, for reducing cardiovascular death, heart attack and stroke, for noncirrhotic MASH and for severe obstructive sleep apnea — and that Wegovy, Zepbound and Saxenda came off the preferred drug list as an off-cycle change, with Saxenda dropped for every indication.
NC Medicaid, Division of Health Benefits, NC Department of Health and Human Services, effective October 2025 · source · read August 2026
Ten weeks later it reversed. The December 2025 bulletin says that "Effective Dec. 12, 2025, coverage for GLP-1s for the treatment of obesity will be reverted to the coverage available as of Sept. 30, 2025," and that this happened "In accordance with the Governor's directive." Wegovy, Zepbound and Saxenda went back on the preferred drug list as an off-cycle change, with Wegovy preferred and the other two non-preferred, and the criteria reverted to the ones effective August 1, 2024. The bulletin also tells prescribers to consider whether a member has had a lapse in treatment and whether a lower starting dose is needed.
NC Medicaid, Division of Health Benefits, NC Department of Health and Human Services, effective December 2025 · source · read August 2026
The current state drug list still carries them. Under "WEIGHT MANAGEMENT AGENTS" it lists a class headed "GLP-1 Receptor Agonists indicated for the treatment of obesity (Incretin Mimemetics)" — the misspelling is the state's — with Wegovy pen and tablet preferred, and Saxenda, generic liraglutide and Zepbound non-preferred. The class carries the note that clinical criteria apply to all drugs in it. This is the list effective July 2026, revised July 24, 2026.
NC Medicaid, Division of Health Benefits, Preferred Drug List, effective July 2026 · source · read August 2026
The criteria are where the real gate is. An adult needs "A BMI greater than or equal to 30 kg/m2 OR A BMI greater than or equal to 27 kg/m2 with at least one weight-related comorbidity/risk factor/complication," with baseline weight and BMI "measured within the past 45 days" recorded on the form, and must be "currently on and will continue lifestyle modification including structured nutrition and physical activity." Renewal is the part people lose on: an adult must show "the patient has lost a total of 5% of pretreatment weight and maintains the 5% weight loss." Approval runs "6 months for the initial approval, 12 months for renewal; no limit on the number of renewals that may be provided," with quantity limits of Wegovy 3 mL per 28 days, Zepbound 2 mL per 28 days and Saxenda 15 mL per 30 days. ⚠ This document carries a DRAFT watermark and a submission footer on every page; we cite it because the December 2025 bulletin names these August 1, 2024 criteria as the ones restored, and because the state's live prior authorization form asks the same questions.
NC Medicaid Outpatient Pharmacy Prior Approval Criteria, GLP-1s for Weight Management, effective August 2024 · source · read August 2026
Your plan cannot make it harder. The state's own factsheet for providers says all health plans "follow the same policy as NC Medicaid Direct does today including following the same single NC Preferred Drug List (PDL)," and that they "are required to follow the same criteria when prior authorization (PA) is required to obtain a medication and cannot apply new or different PA from the PDL." So changing plans will not change the answer, and a plan asking you for something the criteria above do not require is worth questioning.
NC Medicaid Managed Care: What Providers Need to Know About Pharmacy · source · read August 2026
North Carolina runs two different appeal clocks and which one is yours depends on whether you are in a health plan. In managed care you appeal to the plan first, "no later than 60 days after the mailing date of the notice of adverse benefit determination," and only then to the Office of Administrative Hearings, "by no later than 120 days after the mailing date of the notice of resolution." In NC Medicaid Direct there is no plan step and the window is much shorter: "The recipient shall request a hearing within 30 days of the mailing of the notice." Thirty days and sixty days are both on this page because both are real; the notice you were sent says which one you are on.
N.C.G.S. §§108D-13, 108D-15 and 108A-70.9A, North Carolina General Assembly · source · read August 2026
Medicaid is only one of the routes. If you have a commercial or employer plan, the rules are different and are on the employer plans page; Medicare has a federal rule of its own, on the Part D page.
If the appeal fails, or you cannot wait
Cash-pay telehealth is the fallback, not the bargain: you pay the whole cost yourself, and a covered prescription is almost always cheaper than any of these. Use this route when coverage has actually been exhausted, or when you need to start while an appeal runs.
These companies pay us a commission if you start care through the links below. That is how this site is funded, and it does not change what is written above. How we pay for this.
Prices in those notes were read from each company's own site in August 2026 and change often. Check the current number before you buy.
Every state we have verified is in the coverage matrix. Appeal routes and deadlines are on the procedures page.